ASTRO

RELATED CONTENT

Multi-center study achieves durable local control and cancer-specific survival after stereotactic radiation treatment
News | Stereotactic Body Radiation Therapy (SBRT)

High-dose Radiation Offers New Treatment Option for Older Patients ...

October 1, 2023 — Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted ...

Time October 01, 2023
Read more
Study points to options to improve quality of life for patients whose cancer is cured with chemoradiation
News | Women's Health

Sexual Activity and Vaginal Dilation Associated with Fewer Side ...

October 1, 2023 — People who engage in sexual activity or vaginal dilation after chemoradiation treatment for cervical ...

Time October 01, 2023
Read more
Fuse also announces Syntyant, a new interoperable platform for RadOnc providing seamless connectivity among diverse healthcare technologies to accelerate delivery of care
News | Information Technology

Fuse Oncology Unveils FuseDocs: Newest RadOnc Solution for ...

September 29, 2023 — Fuse Oncology (Fuse) a trailblazing leader in radiation oncology software solutions, unveils their ...

Time September 29, 2023
Read more
Phase III trial finds fewer, higher doses cut treatment time while maintaining high rates of cure
News | Prostate Cancer

SBRT as Effective as Conventional Radiation for People with ...

September 29, 2023 — People with intermediate risk, localized prostate cancer can be treated as effectively using fewer ...

Time September 29, 2023
Read more
RayStation 2023B offers support for automatic field-in-field planning for photons, a method which generates homogeneous and conformal dose distributions
News | Oncology Information Management Systems (OIMS)

Latest innovations in RayStation, RayCare and RayIntelligence to be ...

September 29, 2023 — RaySearch will be showcasing the latest software innovations at ASTRO in San Diego, California ...

Time September 29, 2023
Read more
POSLUMA is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer with suspected metastasis
News | Radiopharmaceuticals and Tracers

Blue Earth Diagnostics Highlights Presentations on POSLUMA ...

September 27, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time September 27, 2023
Read more
Researchers seek new ways to treat prostate cancer using relugolix in combination with radiation therapy
News | Radiation Therapy

Winners of the ASTRO-Sumitomo Pharma-Pfizer Alliance New Combination ...

September 27, 2023 — The American Society for Radiation Oncology (ASTRO) announced the three winning research proposals ...

Time September 27, 2023
Read more
Howard Sandler, MD, FASTRO, Radiation Oncology Department Chair at Cedars-Sinai Medical Center (Los Angeles, CA), will take the helm as President of the American Society for Radiation Oncology during ASTRO 2023, to be held October 1-4 in San Diego, CA.
Feature | ASTRO | By Christine Book

Leadership Spotlight: ASTRO Incoming President Discusses Top ...

September 26, 2023 — Ahead of the 65th American Society for Radiation Oncology Annual Meeting, ASTRO 2023, ITN’s ...

Time September 26, 2023
Read more
Advancements in research, technology and partnerships are combining to enhance availability and access
Feature | Proton Therapy | By Christine Book

Targeting Cancer, Tracking Collaboration: A Progress Report on Proton ...

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
Read more
ASTRO is committed to achieving President Biden’s goal of reducing cancer mortality by 50%
News | ASTRO

ASTRO President to Speak at President’s Cancer Panel Meeting About ...

September 7, 2023 — American Society for Radiation Oncology (ASTRO) President Jeff Michalski, MD, MBA, FASTRO, will join ...

Time September 07, 2023
Read more
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now